about
Recent developments in human immunodeficiency virus-1 latency researchPlacental immunopathology in the FIV-infected cat: a role for inflammation in compromised pregnancy?CD4(+)CD25(+) T regulatory cells inhibit CD8(+) IFN-gamma production during acute and chronic FIV infection utilizing a membrane TGF-beta-dependent mechanism.Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.Domain- and nucleotide-specific Rev response element regulation of feline immunodeficiency virus production.Expression of regulatory T cell (Treg) activation markers in endometrial tissues from early and late pregnancy in the feline immunodeficiency virus (FIV)-infected cat.Diversity of trends of viremia and T-cell markers in experimental acute feline immunodeficiency virus infection.Anti-Inflammatory Therapy for Feline Immunodeficiency Virus Infection and Associated AIDS-Like Syndrome.The role of BST2/tetherin in feline retrovirus infectionCanine distemper virus infection leads to an inhibitory phenotype of monocyte-derived dendritic cells in vitro with reduced expression of co-stimulatory molecules and increased interleukin-10 transcription.Effect of Chuanminshen violaceum polysaccharides and its sulfated derivatives on immunosuppression induced by cyclophosphamide in mice.Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas.Vitamin D status in cats with feline immunodeficiency virus.Sequence variation of the feline immunodeficiency virus genome and its clinical relevance.Feline immunodeficiency virus latency.Skin as a marker of general feline health: Cutaneous manifestations of infectious disease.
P2860
Q27013114-36DF165F-BD48-4F9C-995A-0E8895D03F9CQ33653289-560FC68F-36F0-423C-AF37-270B9BFCB8ADQ33714522-76382AF1-BDDE-4157-A325-3FAE886671B4Q33968779-1C566590-8A5B-4234-BFAB-A020F4814FA7Q33987860-2B2FFA36-AEAB-4587-9B2C-988F595AD08BQ34106523-95D919B8-513F-4FC6-87FC-89BBA4B98343Q34586680-2CDE5131-2253-4B1B-9FB3-87BD4B92D43CQ34631387-71B1CFB7-569A-49FC-A7FF-DF53F6000819Q34664616-C2CD138B-AE51-41F6-B230-6290A9A50AB6Q35158077-7D7E61E5-BA2B-4BBA-A925-CD54AC3FE347Q35173528-B3ADC8CD-D4E7-4CB3-A0DB-1655D04AB552Q36153785-668EFA6D-9E67-4454-BA1B-27B6920709A3Q37077101-AC35B745-5413-4C23-8173-F4591BD3DDA7Q38113162-69429177-8136-426C-95B5-871CA58B7712Q38119498-C2AC4D61-52D2-4FB1-A367-1D1F824FF30DQ47601119-0FD1B512-2B22-4639-8EF3-1297113BC6AC
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Lentivirus-induced immune dysregulation.
@ast
Lentivirus-induced immune dysregulation.
@en
type
label
Lentivirus-induced immune dysregulation.
@ast
Lentivirus-induced immune dysregulation.
@en
prefLabel
Lentivirus-induced immune dysregulation.
@ast
Lentivirus-induced immune dysregulation.
@en
P2860
P1476
Lentivirus-induced immune dysregulation.
@en
P2093
Mary B Tompkins
Wayne A Tompkins
P2860
P356
10.1016/J.VETIMM.2008.01.011
P577
2008-01-19T00:00:00Z